Sign in
4

Changes in Ownership

Edesa Biotech, Inc. Filed Acc 0001144204-18-014753

Options or other derivatives

  • Director acquired 2,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
SAMPAT MAYANK D. Director 2018-03-12 Grant or award · Share Option (Right to Buy) +2,500 2,500 D: show line 1 in the form
Loading xslF345X03/tv488521_4.xml…